Prognostic factors: Guidelines for investigation design and state of the art analytical methods

Surgical Oncology

Volumn 7, Issue 1-2, 1998, Pages 71-76

  Drew, P J ^b   Ilstrup, D M ^a   Kerin, M J ^b   Monson, J R T ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL INTELLIGENCE; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MEDICAL LITERATURE; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; REVIEW; STATISTICAL MODEL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0002542867     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(98)00029-2     Document Type: Article

References (31)

1. [1] Clark GM, Hilsenbeck SG, Ravdin PM, De Laurentis M, Osborne CK. Prognostic factors: rationale and methods of analysis and integration. Breast Cancer Research Treatment 1994;32:105-15.
2. [2] Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. American Joint Committee on Cancer. Handbook for staging of cancer. J.B. Lippincott: Philadelphia, 1993.
3. [3] Jass JR, Love SB, Northover JMA. A new prognostic classification of rectal cancer. Lancet 1987;i:1303-6.
4. [4] Fisher ER, Sass R, Palekar A et al. Dukes' classification revisited. Cancer 1989;64:2354-60.
5. [5] Bottaci L, Drew PJ, Hartley JE et al. Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions. Lancet 1997;350:469-72.
6. [6] Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. British Journal of Cancer 1994;69:979-85.
7. [7] Harrell FE, Lee LE, Matchar DB, Reichart TA. Regression models for prognostic prediction: advantages, problems and suggested solutions. Cancer Treatment Reports 1985;69:1071-7.
8. [8] Durrelman S, Simon R. Flexible regresion models with cubic splines. Statistics in Medicine 1989;8:551-61.
9. [9] Schmoor C, Ulm K, Schumaker M. Comparison of the Cox model and the regression tree procedure in analysing a randomised clinical trial. Statistics in Medicine 1993;12:2351-66.
10. [10] Segal MR. Regression trees for censored data. Biometrics 1988;44:35-47.
11. [11] Ciampi A, Lawless JF, McKinney SM, Singhal K. Regression and recursive partition strategies in the analysis of medical survival data. Journal of Clinical Epidemiology 1988;41:737-48.
12. [12] De Laurentis M, Ravdin PM. Survival analysis of censored data: neural network analysis detection of complex interactions between variables. Breast Cancer Research Treatment 1994;32:113-8.
13. [13] Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet 1995;346:1075-9.
14. [14] Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995;346:1135-8.
15. [15] Burke HB, Goodman PH, Rosen DB et al. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 1997;79:857-62.
16. [16] Clark GM, Wenger CR, Beardslee S et al. How to integrate steroid hormone receptor, flow cytometry and other prognostic information for primary breast cancer. Cancer 1993;71: 2157-62.
17. [17] Cox DR. Regression models and life tables. Journal of the Royal Statistical Society 1972;34:187-220.
18. [18] Gregory WM. Adjusting survival curves for imbalances in prognostic factors. British Journal of Cancer 1988;58:202-4.
19. [19] Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham prognostic index in primary breast cancer. Breast Cancer Research Treatment 1992;22:207-19.
20. [20] Hauke WW, Miike R. A proposal for examining and reporting stepwisce regressions. Statistics in Medicine 1991;10:711-5.
21. [21] Chapman JAW, Trudeau ME, Pritchard KI et al. A comparison of all subset and accelerated failure time models with Cox stepwise regression for node-positive breast cancer. Breast Cancer Research Treatment 1993;22:263-72.
22. [22] Altman DG, Anderson PK. Bootstrap investigation of the stability of a Cox regression model. Statistics in Medicine 1989;8:771-83.
23. [23] Hilsenbeck SG, Clark GM, McGuire WL. Why do so many prognostic factors fail to pan out? Breast Cancer Research Treatment 1992;22:197-206.
24. [24] Altman DG. Categorising continuous variables. Cancer 1992; 64:975.
25. [25] Schoenfield D. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 1981;68: 316-9.
26. [26] Thor A, Benz C, Moore D et al. Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic and prognostic correlations. Journal of the National Cancer Institute 1991;83:170-8.
27. [27] Le Blanc M, Crowley J. Relative risk trees for censored survival data. Biometrics 1992;48:411-25.
28. [28] Rumelhart D, Hinton G, Williams R. Learning representations by back-propagating errors. Nature 1986;323:533-6.
29. [29] McGuire W. Breast cancer prognostic factors: evaluation guidelines. Journal of the National Cancer Institute 1991;83:154-5.
30. [30] Goldberger AL. Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bed side. Lancet 1996;347: 1312-4.
31. [31] Schipper HS, Turley EA, Baum M. A new biological framework for cancer research. Lancet 1996;348:1149-51.